approval
saveELREXFIO (ELRANATAMAB) — FDA approval
community read0 votes
Sponsor: PFIZER INC. Form: SOLUTION. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 7
- phase 3 completionCellCarta Biosciences Inc — elranatamab (Phase III Trial Completion)Apr 27, 2026 · 163d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalMar 25, 2026 · 196d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalFeb 19, 2026 · 230d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalJul 10, 2025 · 454d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalJul 8, 2025 · 456d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalDec 13, 2023 · 1029d ago
- approvalELREXFIO (ELRANATAMAB) — FDA approvalAug 14, 2023 · 1150d ago
same company · ±60 days · 6
- approvalPAXLOVID (COPACKAGED): PAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalSep 12, 2024
- approvaltofacitinib citrate ER: XELJANZ (TOFACITINIB CITRATE) — FDA approvalSep 27, 2024
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalSep 27, 2024
- approvalMETHYLPREDNISOLONE — FDA approvalOct 11, 2024
- approvalmarstacimab: HYMPAVZI (MARSTACIMAB-HNCQ) — FDA approvalOct 11, 2024
- approvalMETHYLPREDNISOLONE — FDA approvalOct 11, 2024
comments(0)
5-min edit window · permanent after that